11/14/2024
6:53 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:43 PM | C4 Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:01 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:57 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
11/13/2024
3:58 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
|
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
4:26 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
4:27 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:12 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:30 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
3:31 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:45 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:11 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:37 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:11 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:51 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
3:52 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:06 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:27 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:11 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
5:47 AM | C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/11/2024
3:45 PM | C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2024
3:46 PM | C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:41 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:10 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
7:52 AM | C4 Therapeutics (Filer)
| Form ARS | |
04/29/2024
7:03 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:04 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:16 PM | C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 AM | C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
2024's Must-Watch Stocks! (Ad) Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.  [Unlock Your Report Now] |
03/08/2024
6:28 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:21 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:24 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:26 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
12:11 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
03/04/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:01 AM | C4 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:15 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:20 AM | C4 Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:18 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:21 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:35 AM | C4 Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
12:04 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
9:24 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G | |
02/02/2024
8:34 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/12/2024
3:01 PM | Betta Investment Ltd. (0001990727) (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
01/11/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:15 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/03/2024
3:12 PM | C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:30 PM | C4 Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
12/22/2023
3:05 PM | C4 Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
| Form SC 13G | |
12/12/2023
3:28 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:15 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:21 PM | C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:18 PM | C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CCCC Stock Alerts